SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001104659-23-129501
Filing Date
2023-12-27
Accepted
2023-12-27 08:55:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 tm2332933-7_sc14d9.htm SC 14D9 822902
2 EXHIBIT (E)(4) tm2332933d8_ex99-e4.htm EX-99.(E)(4) 32792
3 GRAPHIC ft_center-bw.jpg GRAPHIC 15685
4 GRAPHIC lg_centerviewpart-4c.jpg GRAPHIC 16627
  Complete submission text file 0001104659-23-129501.txt   902144
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filed by) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-92771 | Film No.: 231514823
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)